Literature DB >> 10405973

Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin.

N M Borradaile1, K K Carroll, E M Kurowska.   

Abstract

Our previous studies showed that replacing the drinking water of rabbits fed a casein-containing diet with either orange juice or grapefruit juice reduced serum low density lipoprotein cholesterol and hepatic cholesteryl ester concentrations. To determine whether the changes observed in rabbits were due to flavonoids present in the juices acting directly on the liver, the effects of hesperetin and naringenin on net apolipoprotein B (apoB) secretion by HepG2 cells were investigated. These flavanones dose-dependently reduced net apoB secretion by up to 81% after a 24 h incubation, while doses of 60 micrograms/mL reduced net apoB secretion by 50% after 4 h. Coincubation with the proteasome inhibitor, MG-132, did not alter the ability of the flavonoids to reduce net apoB secretion over 4 h, suggesting that the flavonoid-induced changes in apoB metabolism were not due to a direct increase in proteasomal activity. However, the flavonoids were unable to reduce net apoB secretion after 4 h in the presence of oleate, suggesting that these compounds may interfere with the availability of neutral lipids for lipoprotein assembly. Furthermore, our 14C-acetate-labeling studies showed a 50% reduction in cholesteryl ester synthesis in the presence of either flavonoid, which could account for the reduction in net apoB secretion caused by incubation with these compounds. These in vitro studies suggest that hesperetin and naringenin may, in part, reduce net apoB secretion by HepG2 cells by inhibiting cholesteryl ester synthesis and that these compounds are good candidates for further in vivo studies to determine whether they are responsible for the cholesterol-lowering properties of dietary citrus juices.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405973     DOI: 10.1007/s11745-999-0403-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  44 in total

Review 1.  Intracellular degradation of newly synthesized apolipoprotein B.

Authors:  Z Yao; K Tran; R S McLeod
Journal:  J Lipid Res       Date:  1997-10       Impact factor: 5.922

2.  Inhibitory effects of oren-gedoku-to and its components on cholesteryl ester synthesis in cultured human hepatocyte HepG2 cells: evidence from the cultured HepG2 cells and in vitro assay of ACAT.

Authors:  H Yotsumoto; T Yanagita; K Yamamoto; Y Ogawa; J Y Cha; Y Mori
Journal:  Planta Med       Date:  1997-04       Impact factor: 3.352

3.  The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.

Authors:  Z M Yao; D E Vance
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Antihyperlipidemic effect of flavonoids from Prunus davidiana.

Authors:  J S Choi; T Yokozawa; H Oura
Journal:  J Nat Prod       Date:  1991 Jan-Feb       Impact factor: 4.050

Review 5.  Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions.

Authors:  R N Thrift; T M Forte; B E Cahoon; V G Shore
Journal:  J Lipid Res       Date:  1986-03       Impact factor: 5.922

6.  Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally.

Authors:  J K Leighton; J Joyner; J Zamarripa; M Deines; R A Davis
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

7.  Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.

Authors:  S G Young; R S Smith; D M Hogle; L K Curtiss; J L Witztum
Journal:  Clin Chem       Date:  1986-08       Impact factor: 8.327

8.  ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools.

Authors:  F Benoist; T Grand-Perret
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-10       Impact factor: 8.311

9.  Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells.

Authors:  S Furukawa; T Hirano
Journal:  Biochim Biophys Acta       Date:  1993-09-29

10.  Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.

Authors:  N Sakata; X Wu; J L Dixon; H N Ginsberg
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

View more
  25 in total

1.  A combination of palm oil tocotrienols and citrus peel polymethoxylated flavones does not influence elevated LDL cholesterol and high-sensitivity C-reactive protein levels.

Authors:  J P Schuchardt; S Heine; A Hahn
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

2.  Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome.

Authors:  Stefano Rizza; Ranganath Muniyappa; Micaela Iantorno; Jeong-a Kim; Hui Chen; Philomena Pullikotil; Nicoletta Senese; Manfredi Tesauro; Davide Lauro; Carmine Cardillo; Michael J Quon
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

3.  Hesperedin promotes MyoD-induced myogenic differentiation in vitro and in vivo.

Authors:  Hana Jeong; Joo Yeon Lee; Eun Jung Jang; Eun Hye Lee; Myung Ae Bae; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications.

Authors:  Kashif M Munir; Sruti Chandrasekaran; Feng Gao; Michael J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-07-30       Impact factor: 4.310

5.  The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells.

Authors:  Brian Morin; LaNita A Nichols; Katherine M Zalasky; J Wade Davis; John A Manthey; Lené J Holland
Journal:  J Nutr       Date:  2008-07       Impact factor: 4.798

6.  Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.

Authors:  Chenlin Shen; Zhengyue Qian; Ruonan Chen; Xiaoming Meng; Tingting Hu; Zhaolin Chen; Yangyang Li; Cheng Huang; Chaojie Hu; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

7.  Exploring the effect of Hesperetin-HSPC complex--a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics.

Authors:  Kuntal Maiti; Kakali Mukherjee; Venkatesh Murugan; Bishnu Pada Saha; Pulok Kumar Mukherjee
Journal:  AAPS PharmSciTech       Date:  2009-07-24       Impact factor: 3.246

8.  Sulfation of dietary flavonoids by human sulfotransferases.

Authors:  C Huang; Y Chen; T Zhou; G Chen
Journal:  Xenobiotica       Date:  2009-04       Impact factor: 1.908

9.  Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin.

Authors:  Elzbieta M Kurowska; John A Manthey; Adele Casaschi; Andre G Theriault
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

10.  Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.

Authors:  Sherine Maher Rizk; Nagwa Ali Sabri
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.